Comprehensive analysis of the drug properties, specifications and packaging information of Fidaxomicin

Fidaxomicin is a new macrolide antibiotic, mainly used to treat Clostridioides difficile infection (CDI), especially for mild, moderate and recurrent cases. The drug has a selective bacteriostatic effect, interfering with bacterial protein synthesis by inhibiting bacterial RNA polymerase, thereby achieving a bactericidal effect while having less interference with normal intestinal flora. Fidaxomicin is an oral preparation and has a low absorption rate. It can reach high concentrations in the intestinal tract and act directly on the infection site.

Fidaxomicin is in the form of White to off-white powder, with good stability and easily soluble in water and some organic solvents. The drug is in the form of oral tablets. Each tablet contains active ingredients, which are released directly through the gastrointestinal tract and reach therapeutic concentrations in the colon. The properties of the drug are stable, and the storage conditions are: Avoid light, seal, and place in a dry place to avoid high temperature and humid environment to ensure efficacy and safety.

The common clinical specification of fidaxomicin is 200mg/ tablets, which are packaged and sold according to the course of treatment. The packaging is mostly in the form of aluminum-plastic plates (blister pack) or bottles. Each box often contains 10 tablets to 30 tablets to meet the needs of different treatment courses. The standard course of treatment is generally 10 days, taken orally twice a day, and can be adjusted appropriately according to the patient's condition and doctor's advice. The packaging information clearly indicates the active ingredients, content, production batch number and expiration date to facilitate correct use by patients and medical staff.

Fidaxomicin can reduce the toxic and side effects caused by systemic absorption by acting locally on the intestines. It is especially suitable for the elderly and patients with renal insufficiency. During use, you should pay attention Strictly follow the package instructions and doctor's instructions, and avoid splitting tablets or adjusting the dosage at will to ensure the efficacy. During storage, transportation and clinical application, drugs should be kept dry, protected from light, and stored at room temperature to ensure drug quality and patient safety.

Reference materials:https://www.drugs.com/